This morning it is going to be interesting to see if the Enzolytics Inc (OTCMKTS:ENZC) stock come into focus among investors or not considering the fact that the company made a major announcement yesterday. It should be noted that last Friday the stock had been trading within a range.
Trading Data
On Friday, ENZC stock fell 1.26% to $0.0907 with more than 4.34 million shares traded, compared to its average volume of 15.89 million shares. The stock moved within a range of $0.0900 – 0.0955 after opening trading at $0.0906.
Enzolytics Announces Its New Technology For Entry Into The In-Vitro Diagnostics Market
Yesterday, Enzolytics announced that it was aiming to enter the lucrative diagnostics space. In this context, it ought to be noted that the company has already completed the filing of a United States and overseas Patent Cooperation Treaty Patent Application which covers its innovative and novel technology meant for diagnostics.
It was also announced that the patent application also includes the epitopes and antigens from the COVID 19 virus which can be deployed in vaccines. It goes without saying that the announcement was a significant one from the company and it is going to be interesting to see how the market reacts today in light of the latest direction adopted by Enzolytics.
The Artificial Intelligence platform that is owned by Enzolytics had been deployed for the purpose of building the 3D models for the conserved targets. It may now be a good move to add the stock to your watch lists.
Technical Data
ENZC stock is trading below the 20-Day and 50-Day Moving averages of $0.0936 and $0.0927 respectively. Moreover, the stock is below the 200-Day moving average of $0.14.
